Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for Elimination of Pelvis Ureteral Stones
NCT00151567Phase 3Completed
- Sponsor
- CHU Rennes
- Start
- Feb 2002
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ureterolithiasis comparing Tamsulosin Arm with Placebo Arm (2 arms). Primary endpoint: Time to stone elimination. Started Feb 2002; status: completed.
02
Drugs
tamsulosin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on NCT00151567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151567.